593 related articles for article (PubMed ID: 25442473)
1. [Acanthosis nigricans in children and Crouzon syndrome].
Lagaude M; Barreau M; Jokic M; Gerard M; DiRocco F; Hadj-Rabia S; Dompmartin A; Verneuil L
Ann Dermatol Venereol; 2014 Nov; 141(11):685-8. PubMed ID: 25442473
[TBL] [Abstract][Full Text] [Related]
2. Crouzon with acanthosis nigricans. Further delineation of the syndrome.
Arnaud-López L; Fragoso R; Mantilla-Capacho J; Barros-Núñez P
Clin Genet; 2007 Nov; 72(5):405-10. PubMed ID: 17935505
[TBL] [Abstract][Full Text] [Related]
3. Crouzon with Acanthosis Nigricans and Odontogenic Tumors: A Rare Form of Syndromic Craniosynostosis.
Xu W; McDonald-McGinn DM; Melchiorre AJ; Zackai EH; Bartlett SP; Taylor JA
Cleft Palate Craniofac J; 2018 Feb; 55(2):296-300. PubMed ID: 29351036
[TBL] [Abstract][Full Text] [Related]
4. A newborn with acanthosis nigricans: can it be Crouzon syndrome with acanthosis nigricans?
Sharda S; Panigrahi I; Gupta K; Singhi S; Kumar R
Pediatr Dermatol; 2010; 27(1):43-7. PubMed ID: 20199409
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous features of Crouzon syndrome with acanthosis nigricans.
Mir A; Wu T; Orlow SJ
JAMA Dermatol; 2013 Jun; 149(6):737-41. PubMed ID: 23571469
[TBL] [Abstract][Full Text] [Related]
6. An association of acanthosis nigricans and Crouzon syndrome.
Koizumi H; Tomoyori T; Sato KC; Ohkawara A
J Dermatol; 1992 Feb; 19(2):122-6. PubMed ID: 1377724
[TBL] [Abstract][Full Text] [Related]
7. Crouzon syndrome with acanthosis nigricans and prominent diffuse hyperpigmentation associated with gain-of-function A391E mutation in FGFR3 gene.
Kariya H; Nakano H; Ishii N; Kaimi Y; Imai K; Nakanishi Y; Kunihiro N; Fukai K
J Dermatol; 2020 Dec; 47(12):e451-e452. PubMed ID: 32860240
[No Abstract] [Full Text] [Related]
8. Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans.
Meyers GA; Orlow SJ; Munro IR; Przylepa KA; Jabs EW
Nat Genet; 1995 Dec; 11(4):462-4. PubMed ID: 7493034
[TBL] [Abstract][Full Text] [Related]
9. Expanding the phenotype for the recurrent p.Ala391Glu variant in FGFR3: Beyond crouzon syndrome and acanthosis nigricans.
Rymer K; Shiang R; Hsiung A; Pandya A; Bigdeli T; Webb BT; Rhodes J
Mol Genet Genomic Med; 2019 Jun; 7(6):e656. PubMed ID: 31016899
[TBL] [Abstract][Full Text] [Related]
10. The molecular and genetic basis of fibroblast growth factor receptor 3 disorders: the achondroplasia family of skeletal dysplasias, Muenke craniosynostosis, and Crouzon syndrome with acanthosis nigricans.
Vajo Z; Francomano CA; Wilkin DJ
Endocr Rev; 2000 Feb; 21(1):23-39. PubMed ID: 10696568
[TBL] [Abstract][Full Text] [Related]
11. Crouzon syndrome with acanthosis nigricans: case report and mutational analysis.
Nagase T; Nagase M; Hirose S; Ohmori K
Cleft Palate Craniofac J; 2000 Jan; 37(1):78-82. PubMed ID: 10670894
[TBL] [Abstract][Full Text] [Related]
12. Crouzon syndrome with acanthosis nigricans: a case-based update.
Di Rocco F; Collet C; Legeai-Mallet L; Arnaud E; Le Merrer M; Hadj-Rabia S; Renier D
Childs Nerv Syst; 2011 Mar; 27(3):349-54. PubMed ID: 21136065
[TBL] [Abstract][Full Text] [Related]
13. Subtle radiographic findings of achondroplasia in patients with Crouzon syndrome with acanthosis nigricans due to an Ala391Glu substitution in FGFR3.
Schweitzer DN; Graham JM; Lachman RS; Jabs EW; Okajima K; Przylepa KA; Shanske A; Chen K; Neidich JA; Wilcox WR
Am J Med Genet; 2001 Jan; 98(1):75-91. PubMed ID: 11426459
[TBL] [Abstract][Full Text] [Related]
14. Mild achondroplasia/hypochondroplasia with acanthosis nigricans, normal development, and a p.Ser348Cys FGFR3 mutation.
Couser NL; Pande CK; Turcott CM; Spector EB; Aylsworth AS; Powell CM
Am J Med Genet A; 2017 Apr; 173(4):1097-1101. PubMed ID: 28181399
[TBL] [Abstract][Full Text] [Related]
15. [Presentation of two cases of Crouzon syndrome: allelic cranio-stenotic conditions of FGFR genes].
Vidal Sanahuja R; Gean Molins E; Sánchez Garré C; Quilis Esquerra J; García Fructuoso G; Costa Clara JM
An Pediatr (Barc); 2012 Oct; 77(4):272-8. PubMed ID: 22633821
[TBL] [Abstract][Full Text] [Related]
16. Clinical signs, interventions, and treatment course of three different treatment protocols in patients with Crouzon syndrome with acanthosis nigricans.
de Planque CA; Wall SA; Dalton L; Paternoster G; Arnaud É; van Veelen MC; Versnel SL; Johnson D; Jayamohan J; Mathijssen IMJ
J Neurosurg Pediatr; 2021 Aug; 28(4):425-431. PubMed ID: 34388723
[TBL] [Abstract][Full Text] [Related]
17. A recurrent mutation, ala391glu, in the transmembrane region of FGFR3 causes Crouzon syndrome and acanthosis nigricans.
Wilkes D; Rutland P; Pulleyn LJ; Reardon W; Moss C; Ellis JP; Winter RM; Malcolm S
J Med Genet; 1996 Sep; 33(9):744-8. PubMed ID: 8880573
[TBL] [Abstract][Full Text] [Related]
18. Crouzon syndrome with acanthosis nigricans: a case report and literature review.
Nguyen QD; Tran TNA; Nguyen HT
Dermatol Reports; 2023 Jun; 15(2):9620. PubMed ID: 37397405
[TBL] [Abstract][Full Text] [Related]
19. A rare association of acanthosis nigricans with Crouzon syndrome.
Gupta AK; Koley S; Choudhary S; Bhake A; Saoji V; Salodkar A
Indian J Dermatol Venereol Leprol; 2010; 76(1):65-7. PubMed ID: 20061739
[No Abstract] [Full Text] [Related]
20. Familial acanthosis nigricans due to K650T FGFR3 mutation.
Berk DR; Spector EB; Bayliss SJ
Arch Dermatol; 2007 Sep; 143(9):1153-6. PubMed ID: 17875876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
